News‎ > ‎Full Stories‎ > ‎

14 February 2017

posted Feb 14, 2017, 5:13 AM by Beck Lockwood   [ updated Feb 14, 2017, 6:23 AM ]
Dr Mike Messenger
Precision medicine on CSO conference agenda

Personalised medicine and health will be on the agenda at this year’s Chief Scientific Officers (CSO) Conference, due to take place in London on 6-7 March 2017. Dr Mike Messenger, Deputy Director of the National Institute for Health Research Diagnostic Evidence Co-operative Leeds will be attending to speak about the newly established Leeds Centre for Personalised Medicine and Health (LCPMH).

Personalised medicine is a process by which the decisions made about health and care by patients and the public, supported by clinicians, are enriched and improved by the availability of the best possible information, technology and evidence.

The LCPMH is a collaboration between Leeds’ universities and NHS Trusts, commissioning groups and council that will work to accelerate research, evaluation and implementation of new treatments and technologies. Through this, the Centre will enable the city’s population to benefit from the latest innovations in personalised medicine and health.

“We want to make the UK internationally competitive in this field,” says Dr Messenger. “Our aim is to improve decision-making in the health and care system by taking the lead on creating personalised medicine and health resources that can be implemented across Leeds, initially, and then across the UK and beyond.”

Organised by the National School of Health Sciences, the CSO Conference attracts world-class speakers and experts in their field to discuss current issues in heath and care. Also presenting material at the event will be Dr Darren Treanor, Consultant Pathologist and head of the Leeds Digital Pathology Group.